This is implied by the author’s declaration “CD19+ B-lymphocytes and CLL cells had remained undetectable or highly suppressed (less than 1% of cells) beyond 3 years post-infusion” [7]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.